Market Cap: $2.5825T -3.89%
Volume(24h): $122.7307B -31.11%
  • Market Cap: $2.5825T -3.89%
  • Volume(24h): $122.7307B -31.11%
  • Fear & Greed Index:
  • Market Cap: $2.5825T -3.89%
Cryptos
Topics
Cryptospedia
News
CryptosTopics
Videos
Top News
Cryptos
Topics
Cryptospedia
News
CryptosTopics
Videos
bitcoin
bitcoin

$76009.435780 USD

-1.53%

ethereum
ethereum

$2375.311573 USD

-2.24%

tether
tether

$0.999942 USD

0.01%

bnb
bnb

$682.047535 USD

-2.01%

xrp
xrp

$1.441787 USD

-5.55%

usd-coin
usd-coin

$1.000052 USD

0.00%

solana
solana

$92.061879 USD

-1.80%

tron
tron

$0.342038 USD

-0.93%

hyperliquid
hyperliquid

$77.587999 USD

-1.41%

dogecoin
dogecoin

$0.089327 USD

-2.08%

zcash
zcash

$782.134934 USD

-0.71%

unus-sed-leo
unus-sed-leo

$9.484522 USD

0.92%

chainlink
chainlink

$11.132242 USD

-5.45%

monero
monero

$431.110612 USD

0.39%

cardano
cardano

$0.214545 USD

-7.12%

Cryptocurrency News Articles

Another Nasdaq Listed Company to Acquire $1 Billion in BTC

May 17, 2025 at 04:48 pm

One More Nasdaq Listed Company has announced it is entering exclusive negotiations for a landmark acquisition of $100M in Bitcoin (BTC).

Another Nasdaq Listed Company to Acquire $1 Billion in BTC

One More Nasdaq Listed Company Has Announced It Is Entering Exclusive Negotiations for a Landmark Acquisition of $1 Billion in Bitcoin (BTC).

This step will see Basel Medical Group Ltd (Nasdaq: BMGL) diversify its treasury reserves significantly while allowing the company to maintain its primary focus on expanding its medical services across Asia. The move marks a strategic financial initiative aimed at bolstering its balance sheet and supporting its ambitious growth in high-demand healthcare markets.

The company is currently in advanced talks with a consortium of institutional investors and high-net-worth individuals within the cryptocurrency sector. Through an innovative share-swap arrangement, BMGL plans to acquire the $1 billion in Bitcoin. If successful, this acquisition will be one of the largest corporate balance sheet improvements in the Asia-Pacific healthcare industry.

The proposed BTC acquisition will provide multiple strategic benefits to BMGL:

BMGL will be positioned as a well-capitalized player in emerging Asian healthcare markets, with increased resources for expansion.

This acquisition aligns with BMGL's commitment to exploring cutting-edge financial instruments and technologies.

The move is anticipated to generate significant interest from investors and the financial press, enhancing BMGL's visibility and brand recognition.

The acquisition is expected to be finalized by the end of the current quarter, pending standard closing conditions and any required regulatory approvals.

“We are excited about the potential of this $1 billion acquisition to provide us with the unprecedented financial capacity to drive our growth strategy in Asia, all while maintaining disciplined financial management,” said Dr. Darren Chhoa, CEO of Basel Medical Group.

“This will strengthen our balance sheet and position us for swift execution as we capitalize on strategic opportunities to build a leading healthcare platform across the high-growth Asian markets.”

The company will keep investors informed of any material developments in due course.

Original source:coindoo

Disclaimer:info@kdj.com

The information provided is not trading advice. kdj.com does not assume any responsibility for any investments made based on the information provided in this article. Cryptocurrencies are highly volatile and it is highly recommended that you invest with caution after thorough research!

If you believe that the content used on this website infringes your copyright, please contact us immediately (info@kdj.com) and we will delete it promptly.

Other articles published on Aug 23, 2026